PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 123 | 192-207
Article title

The multiple HPV infections and their possible significance in predicting the risk of the cervical cancer

Content
Title variants
Languages of publication
EN
Abstracts
EN
Infections with human papillomavirus (HPV) are detected frequently. The occurrence of persistent infection with oncogenic HPV type associates with the development of cervical cancer. However, the part of HPV infections consist of the multiple viral types. The influence of HPV co-infections on the risk of the development of cervical cancer is not clear, but the occurrence of more than one viral type seems to increase the risk of advanced lesions of the uterine cervix. Additionally, possible interactions (both positive and negative) between particular HPV types in co-infections may influence the risk of the lesions progression. Although, the issue of HPV co-infections is not well known, the previous scientific reports make that the introduction of the molecular methods, allowing the identification not only single but also multiple HPV infections, in routine diagnostics seem to be important. Here, we present the PCR-RFLP and Real-Time PCR methods as the useful tools in the diagnostics of HPV infections.
Year
Volume
123
Pages
192-207
Physical description
Contributors
  • Department of Microbiology and Genetics, Faculty of Biological Sciences, University of Zielona Góra, 21b Monte Cassino Str., 65-561 Zielona Góra, Poland
  • Department of Microbiology and Genetics, Faculty of Biological Sciences, University of Zielona Góra, 21b Monte Cassino Str., 65-561 Zielona Góra, Poland
  • Department of Microbiology and Genetics, Faculty of Biological Sciences, University of Zielona Góra, 21b Monte Cassino Str., 65-561 Zielona Góra, Poland
References
  • [1] Abreu A.L., Souza R.P., Gimenes F., Consolaro M.E.: A review of methods for detect human Papillomavirus infection. Virology Journal 9 (2012) 262
  • [2] Bachtiary B., Obermair A., Dreier B., Birner P., Breitenecker G., Knocke T.H., Selzer E., Pötter R.: Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. International Journal of Cancer 102 (2002) 237-243
  • [3] Bardin A., Vaccarella S., Clifford G.M., Lissowska J., Rekosz M., Bobkiewicz P., Kupryjańczyk J., Krynicki R., Jonska-Gmyrek J., Danska-Bidzinska A., Snijders P.J.F., Meijer C.J.L.M., Zatonski W., Franceschi S.: Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. European Journal of Cancer 44 (2008) 557-564
  • [4] Bello B.D., Spinillo A., Alberizzi P., Cesari S., Gardella B., D’Ambrosio G., Roccio M., Silini E.M.: Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. Journal of Medical Virology 81 (2009) 703-712
  • [5] Bergvall M., Melendy T., Archambault J.: The E1 proteins. Virology 445 (2013) 35-56
  • [6] Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H. zur, de Villiers E.M.: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401 (2010) 70-79
  • [7] Biryukov J., Meyers C.: Superinfection exclusion between two high-risk human papillomavirus types during a coinfection. Journal of Virology 92 (2018) e01993-17
  • [8] Bruni L., Albero G., Serrano B., Mena M., Gómez D., Muñoz J., Bosch F. X., de Sanjosé S.: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 22 January 2019.
  • [9] Bruni L., Albero G., Serrano B., Mena M., Gómez D., Muñoz J., Bosch F. X., de Sanjosé S.: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Poland. Summary Report 10 December 2018.
  • [10] Bruni L., Diaz M., Castellsagué M., Ferrer E., Bosch F.X., de Sanjosé S.: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Journal of Infectious Diseases 202 (2010) 1789-1799
  • [11] Buck C.B., Day P.M., Trus B.L.: The papillomavirus major capsid protein L1. Virology 445 (2013) 169-174
  • [12] Bzhalava D., Eklund C., Dillner J.: International standardization and classification of human papillomavirus types. Virology 476 (2015) 341-344
  • [13] Bzhalava D., Guan P., Franceschi S., Dillner J., Clifford G.: A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 445 (2013) 224-231
  • [14] Carrillo-García A., Ponce-de-León-Rosales S., Cantú-de-León D., Fragoso-Ontiveros V., Martínez-Ramírez I., Orozco-Colín A., Mohar A., Lizano M.: Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. Gynecologic Oncology 134 (2014) 534-539
  • [15] Chen L., Watanabe K., Haruyama T., Kobayashi N.: Simple and rapid human papillomavirus genotyping method by restriction fragment length polymorphism analysis with two restriction enzymes. Journal of Medical Virology 85 (2013) 1229-1234
  • [16] Crow J.M.: HPV: The global burden. Nature 488 (2012) S2–S3;
  • [17] Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C., Gilkisson G., McGoogan E.: Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. Journal of Clinical Pathology 57 (2004) 68-72
  • [18] Day P.M., Baker C.C., Lowy D.R., Schiller J.T.: Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proceedings of the National Academy of Sciences 101 (2004) 14252-14257
  • [19] Dickson E.L., Vogel R.I., Bliss R.L., Downs L.S.: Multiple-type HPV infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. International Journal of Gynecological Cancer 23 (2013) 1295-1302
  • [20] DiGiuseppe S., Bienkowska-Haba M., Guion L.G., Sapp M.: Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus. Virus Research 231 (2017) 1-9
  • [21] DiGiuseppe S., Luszczek W., Keiffer T.R., Bienkowska-Haba M., Guion L.G.M., Sapp M.J.: Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis. Proceedings of the National Academy of Sciences 113 (2016) 6289-6294
  • [22] DiMaio D., Petti L.M.: The E5 proteins. Virology 445 (2013) 99-114
  • [23] Doorbar J.: The E4 protein; structure, function and patterns of expression. Virology 445 (2013) 80-98
  • [24] Doorbar J., Quint W., Banks L., Bravo I.G., Stoler M., Broker T.R., Stanley M.A.: The Biology and Life-Cycle of Human Papillomaviruses. Vaccine 30 (2012) F55-F70
  • [25] Dreer M., van de Poel S., Stubenrauch F.: Control of viral replication and transcription by the papillomavirus E8^E2 protein. Virus Research 231 (2017) 96-102
  • [26] Gradíssimo Oliveira A., Delgado C., Verdasca N., Pista Â.: Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia. Clinical Microbiology and Infection 19 (2013) E447-E450
  • [27] Janiszewska M., Kulik T., Dziedzic M., Żołnierczuk-Kieliszek D.: Śródnabłonkowa neoplazja raka szyjki macicy – diagnoza, profilaktyka. Hygeia Public Health 50 (2015) 63–69
  • [28] Luostarinen T., af Geijersstam V., Bjørge T., Eklund C., Hakama M., Hakulinen T., Jellum E., Koskela P., Paavonen J., Pukkala E., Schiller J.T., Thoresen S., Youngman L.D., Dillner J., Lehtinen M.: No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. International Journal of Cancer 80 (1999) 818-822
  • [29] McBride A.A.: The Papillomavirus E2 proteins. Virology 445 (2013) 57-79
  • [30] McBride A.A.: Playing with fire: consequences of human papillomavirus DNA replication adjacent to genetically unstable regions of host chromatin. Current Opinion in Virology 26 (2017) 63-68
  • [31] McLaughlin-Drubin M.E., Meyers C.: Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 321 (2004) 173-180
  • [32] Mori S., Kusumoto-Matsuo R., Ishii Y., Takeuchi T., Kukimoto I.: Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases. Virology Journal 11 (2014) 11
  • [33] Munagala R., Donà M.G., Rai S.N., Jenson A.B., Bala N., Ghim S.J., Gupta R.C.: Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. International Journal of Oncology 34 (2009) 263-271
  • [34] Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J.: Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine 348 (2003): 518-527
  • [35] Nagao S., Yoshinouchi M., Miyagi Y., Hongo A., Kodama J., Itoh S., Kudo T.: Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative Real-Time PCR. Journal of Clinical Microbiology 40 (2002) 863-867
  • [36] Nobre R.J., de Almeida L.P., Martins T.C.: Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. Journal of Clinical Virology 42 (2008) 13-21
  • [37] Nogueira Dias Genta M.L., Martins T.R., Mendoza Lopez R.V., Sadalla J.C., de Carvalho J.P.M., Baracat E.C., Levi J.E., Carvalho J.P.: Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival. PLOS ONE 12 (2017) e0182854
  • [38] Olejniczak T., Rabiega-Gmyrek D., Niepsuj-Biniaś J., Jachowski P., Guglas-Bochyńska B., Latos-Bieleńska A., Woźniak J., Opala T.: Ocena genotypów wirusów brodawczaka ludzkiego u kobiet z nieprawidłową cytologią. Ginekologia Polska 86 (2015) 541-546
  • [39] Peitsaro P., Johansson B., Syrjanen S.: Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative Real-Time PCR technique. Journal of Clinical Microbiology 40 (2002) 886-891
  • [40] Pett M., Coleman N.: Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? The Journal of Pathology 212 (2007) 356-367
  • [41] Pyeon D., Pearce S.M., Lank S.M., Ahlquist P., Lambert P.F.: Establishment of human papillomavirus infection requires cell cycle progression. PLOS Pathogens 5 (2009) e1000318
  • [42] Roman A., Munger K.: The papillomavirus E7 proteins. Virology 445 (2013) 138-168
  • [43] Salazar K.L., Zhou H.S., Xu J., Peterson L.E., Schwartz M.R., Mody D.R., Ge Y.: Multiple human papilloma virus infections and their impact on the development of high-risk cervical lesions. Acta Cytologica 59 (2015) 391-398
  • [44] Santiago E., Camacho L., Junquera M.L., Vázquez F.: Full HPV typing by a single restriction enzyme. Journal of Clinical Virology 37 (2006) 38-46
  • [45] Senapati R., Nayak B., Kar S.K., Dwibedi B.: HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes. PLOS ONE 12 (2017) e0187844
  • [46] Silins I., Wang Z., \AAvall-Lundqvist E., Frankendal B., Vikmanis U., Sapp M., Schiller J.T., Dillner J.: Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. Journal of General Virology, 80 (1999) 2931-2936
  • [47] Sobota R.S., Ramogola-Masire D., Williams S.M., Zetola N.M.: Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer. Infectious Agents and Cancer 9 (2014) 26
  • [48] Szostek S., Klimek M., Zawilinska B., Kosz-Vnenchak M.: Genotype-specific human papillomavirus detection in cervical smears. Acta Biochimica Polonica 55 (2008) 687–692;
  • [49] Vaccarella S., De Vuyst H., Mugo N.R., Sakr S.R., Plummer M., Heideman D.A.M., Franceschi S., Chung M.: Clustering patterns of human papillomavirus infections among HIV-positive women in Kenya. Infectious Agents and Cancer 8 (2013) 50
  • [50] Vande Pol S.B., Klingelhutz A.J.: Papillomavirus E6 oncoproteins. Virology 445 (2013) 115-137
  • [51] Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189 (1999) 12-19
  • [52] Wang J.W., Roden R.B.S.: L2, the minor capsid protein of papillomavirus. Virology 445 (2013) 175–186
  • [53] Wang L., Wang P., Ren Y., Du J., Jiang J., Jia X., Chen C., Wang Y.: Prevalence of high-risk human papillomavirus (HR-HPV) genotypes and multiple infections in cervical abnormalities from Northern Xinjiang, China. PLOS ONE 11 (2016) e0160698
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-5c2a5a52-0aa2-4705-8cf7-93573e14678f
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.